1. Rationale and Clinical Research Progress on PD-1/PD-L1-Based Immunotherapy for Metastatic Triple-Negative Breast Cancer
    Yifan Ren et al, 2022, International Journal of Molecular Sciences CrossRef
  2. Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance
    Roberto Campagna et al, 2023, Human Cell CrossRef
  3. The impact of HER2-low status on response to neoadjuvant chemotherapy in clinically HER2-negative breast cancer
    Wei Wang et al, 2022, Clinical and Translational Oncology CrossRef
  4. The effect of silencing the Tip60 gene on the response to radiotherapy in breast cancer cells
    Ece Miser-Saliho─člu et al, 2023, The Breast CrossRef